其次措施。
主要结局指标。
Main outcome measures Pupil diameter.
主要指标瞳孔直径。
Main Outcome Measures Absorbance and apoptosis index.
主要指标吸光度，凋亡指数。
Main Outcome Measures LOD score, STR, linkage analysis.
主要指标LOD值，STR位点，连锁分析。
Main Outcome Measures Intraocular pressure of model eye.
主要指标模拟眼眼压曲线。
The primary outcome measures will be cardiovascular risk factors.
心血管风险因素是最主要的疗效判定指标。
Main Outcome Measures Incidence of MCI and rate of decline in cognitive function.
主要结果测定mci的发病和认知功能下降的比率。
There were no differences in the primary outcome measures at 1 year in the ITT analysis.
经itt分析，1年时主要治疗结果的差异没有统计学意义。
These decisions must be evaluated with objective outcome measures to ensure effectiveness.
这些决策必须用客观方法进行评价，以保证其功效。
Main outcome measures Women had three cognitive assessments at two year intervals by telephone.
主要结果的测量方法：妇女每隔两年通过电话有三项认知评估。
Commonly reported outcome measures do reflect patient satisfaction after revision hip arthroplasty.
这些得分能反映术后的满意程度。
The currently available outcome measures are also insensitive to the targeted mechanistic end points.
目前可用的观测指标也对针对机制效果不敏感。
Main Outcome Measures Invasive breast cancer event (recurrence or new primary) or death from any cause.
主要结果检测浸润性乳腺癌的发生(复发或者新发)或者任何原因的死亡。
Main Outcome Measures: Torsion, bending, and axial stiffness and axial failure force after cyclic loading.
主要测量指标：扭转、弯曲和轴向刚度，以及循环载荷下轴向失效力。
Main Outcome Measures: We measured incidence, clinical presentation, and course of postpartum thyroiditis.
主要观察指标：我们观察了产后甲状腺炎的发病率、临床表现和发病过程。
Main outcome measures were health service and societal costs and cost per quality-adjusted life-year gained.
主要的结果评价标准为医疗服务花费、社会成本和获得的平均生命质量调整年。
TABLE 2 lists the clinical outcome measures in the pioglitazone and control groups of the 19 individual trials.
表2列举了吡格列酮及对照组共19项试验的临床结果。
Main Outcome Measures Edema index (e value), signal width value (w value) and features of reflectance pictures.
主要指标水肿指数e和信号宽度W及反射图的形态特征。
Main Outcome Measures: Findings from commonly used hyperactivity ratings, attention tests, and sleepiness tests.
主要结果测量：通常用活动分级、注意力检测和睡意测试来观察。
Should patient satisfaction scores replace functional outcome measures such as ASIA motor, SF-36, and WISCI scores?
患者的满意度评分应该替代功能性结果测量如asia运动评分、SF - 36和WISCI评分吗？
Main Outcome Measures Rates of the 3 types of surgery, major complications, postoperative mortality, and resource use.
主要观察3种手术的指标率，主要并发症，术后死亡率和资源利用。
MAIN OUTCOME MEASURES: the morphological changes of cryptorchidism, and the sorting results of spermatogonial stem cells.
主要观察指标：隐睾的形态学变化，精原干细胞分选结果。
MAIN OUTCOME MEASURES: The three dimensional model and finite element model of lumbar spine were successfully established.
主要结局观察：成功建立了腰椎运动节段的三维模型和有限元模型。
MAIN OUTCOME MEASURES: Positive cellular percentage, density and grayscale of heat shock protein 70 in the rats' hippocampus.
主要观察指标：大鼠海马热休克蛋白70阳性细胞百分率、密度和灰度值。
MAIN OUTCOME MEASURES: Relationship of the incidence of diabetes with the risk factors such as blood lipid and body mass index.
主要观察指标：糖尿病的患病率、血脂、人体质量指数等糖尿病发病的危险因素与糖尿病患病率的关系。
Main outcome measures All cause mortality and cause specific mortality with the main focus on cancer and cardiovascular disease.
主要的评价结果指标：全死因死亡率以及恶性肿瘤、心血管疾病死亡专率。
MAIN OUTCOME MEASURES: Distribution and degree of calcium accumulation and neuronal damage in the thalamus of rats in each group.
主要观察指标：观察各组大鼠丘脑钙积聚与神经元损害的分布和程度。
MAIN OUTCOME MEASURES: Correlation among depression, anxiety, physical factor and social factor of patients with cerebral infarction.
主要观察指标：抑郁、焦虑与脑梗死患者躯体因素及社会因素的相关性。
Main Outcome Measures The primary end point was a composite of initial fatal or nonfatal coronary event or stroke or revascularization.
复合终点为初次致命或非致命性冠状动脉事件、卒中和血管重建。
应用推荐